CONSTELLATION PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY20 | FY19 | FY18 | FY17 | FY16 | |
|---|---|---|---|---|---|
| Revenue | — | — | $0 | $0 | $0 |
| Operating income | −$124.8M | −$86.1M | −$61.2M | −$39.1M | −$33.7M |
| Net income | −$25.4M | −$19.4M | −$59.9M | −$35.4M | −$34.5M |
| Total assets | $441.9M | $399.1M | $118.9M | $19.1M | — |
| Total liabilities | $31.1M | $61.5M | $14.8M | $11.7M | — |
| Equity | $410.7M | $337.6M | $104.2M | −$165.8M | −$131.7M |
| EPS (diluted) | — | — | — | — | — |
| Shares out. | 41.8M | 25.8M | 25.8M | 962,898 | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2020- Operating margin
- —
- Net margin
- —
- Return on equity
- −6.2%
- Return on assets
- −5.8%
- Return on capital (ROCE)
- −30.4%
- Liabilities / assets
- 7.0%
- Debt / equity
- 0.08×
- Book value / share
- $9.82
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2020- Altman Z″ (distress)
- 14.58safe
- Accruals / assets
- 19.5%high accruals
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 warning● 2 good- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJul 15, 2021
- Shareholder voteJun 2, 2021
- Entered a material agreement · Other material eventJun 2, 2021
- Other material eventDec 7, 2020
- Entered a material agreementNov 18, 2020
- Terminated a material agreementNov 9, 2020
- Entered a material agreement · Other material eventJun 17, 2020
- Other material eventJun 15, 2020
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BJul 26, 2021
- 4/APRIMARY DOCUMENTJul 23, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- 4PRIMARY DOCUMENTJul 19, 2021
- EFFECTJul 16, 2021
- S-8 POSJul 15, 2021
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.